Literature DB >> 26201438

Angiographic Evaluation of Coronary Microvascular Dysfunction in Patients with Heart Failure and Preserved Ejection Fraction.

Vincenzo Sucato1, Salvatore Evola1, Giuseppina Novo1, Angela Sansone1, Angelo Quagliana1, Giuseppe Andolina1, Pasquale Assennato1, Salvatore Novo1.   

Abstract

BACKGROUND: The aim of this study was to evaluate myocardial perfusion and coronary blood flow through validated angiography indices to assess whether there is greater MVD in patients with microvascular angina and HFPEF compared to those who do not have.
METHODS: Our study was performed on a population of 286 patients with stable angina that underwent coronary angiography and echocardiography. They showed epicardial coronary arteries free from stenosis. We divided the sample into two categories: patients with HFPEF and those without. We calculated indices for each patient based on angiographic images, including TFC, MBG, and TMBS.
RESULTS: Our sample compared two groups: HFPEF (n = 155) and non-HFPEF (n = 135) patients. We showed that patients with HFPEF had a longest TFC of three major coronary arteries (TFC LAD 44.7 ± 12.5; TFC RCA 26.2 ± 6.9; TFC CX 27 ± 5.9) than non-HFPEF patients (TFC LAD 40.7 ± 11.6; TFC RCA 25 ± 6.3; TFC CX 21 ± 4.7). On the other hand, we found lower MBG on three coronary arteries (MBG LAD 2.1 ± 0.3; MBG RCA 2.1 ± 0.3; MBG CX 2.0 ± 0.32) in HFPEF than non-HFPEF patients (MBG LAD 2.6 ± 0.5; MBG RCA 2.2 ± 0.47; MBG CX 2.3 ± 0.4).
CONCLUSION: Analysis of microcirculation through angiography indices in patients with and without HFPEF has led to assess that the HFPEF population has a greater involvement of microcirculation than patients without HFPEF.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  coronary angiography; echocardiography; heart failure with preserved ejection fraction; inflammation; metabolic syndrome; microvascular angina

Mesh:

Year:  2015        PMID: 26201438     DOI: 10.1111/micc.12223

Source DB:  PubMed          Journal:  Microcirculation        ISSN: 1073-9688            Impact factor:   2.628


  14 in total

Review 1.  Deep Phenotyping of Systemic Arterial Hemodynamics in HFpEF (Part 2): Clinical and Therapeutic Considerations.

Authors:  Julio A Chirinos
Journal:  J Cardiovasc Transl Res       Date:  2017-04-11       Impact factor: 4.132

2.  Frequency of Coronary Microvascular Dysfunction and Diffuse Myocardial Fibrosis (Measured by Cardiovascular Magnetic Resonance) in Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.

Authors:  Adrián I Löffler; Jonathan A Pan; Pelbreton C Balfour; Peter W Shaw; Yang Yang; Moiz Nasir; Daniel A Auger; Frederick H Epstein; Christopher M Kramer; Li-Ming Gan; Michael Salerno
Journal:  Am J Cardiol       Date:  2019-08-22       Impact factor: 2.778

Review 3.  Microvascular Dysfunction in Heart Failure with Preserved Ejection Fraction: Pathophysiology, Assessment, Prevalence and Prognosis.

Authors:  Joanna M Bilak; Uazman Alam; Christopher A Miller; Gerry P McCann; Jayanth R Arnold; Prathap Kanagala
Journal:  Card Fail Rev       Date:  2022-07-01

4.  Left Ventricular Diastolic Function: Comparison of Slow Coronary Flow Phenomenon and Left Ventricular Hypertrophy in the Absence of Obstructive Coronary Disease.

Authors:  Niya E Semerdzhieva; Stefan V Denchev; Mariana V Gospodinova
Journal:  Cureus       Date:  2022-05-06

5.  Reduced Myocardial Flow Reserve Is Associated With Diastolic Dysfunction and Decreased Left Atrial Strain in Patients With Normal Ejection Fraction and Epicardial Perfusion.

Authors:  Matthew C Konerman; Joshua C Greenberg; Theodore J Kolias; James R Corbett; Ravi V Shah; Venkatesh L Murthy; Scott L Hummel
Journal:  J Card Fail       Date:  2017-10-16       Impact factor: 5.712

6.  Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: PROMIS-HFpEF.

Authors:  Sanjiv J Shah; Carolyn S P Lam; Sara Svedlund; Antti Saraste; Camilla Hage; Ru-San Tan; Lauren Beussink-Nelson; Ulrika Ljung Faxén; Maria Lagerström Fermer; Malin A Broberg; Li-Ming Gan; Lars H Lund
Journal:  Eur Heart J       Date:  2018-10-01       Impact factor: 29.983

Review 7.  Physiological Consequences of Coronary Arteriolar Dysfunction and Its Influence on Cardiovascular Disease.

Authors:  Hassan Allaqaband; David D Gutterman; Andrew O Kadlec
Journal:  Physiology (Bethesda)       Date:  2018-09-01

8.  Increased index of microcirculatory resistance in older patients with heart failure with preserved ejection fraction.

Authors:  Zhuo Xu; Hui-Ping Gu; Yang Gu; Wei Sun; Kun Yu; Xi-Wen Zhang; Xiang-Qing Kong
Journal:  J Geriatr Cardiol       Date:  2018-11       Impact factor: 3.327

Review 9.  Coronary Microcirculation in Aortic Stenosis.

Authors:  Hannah Z R McConkey; Michael Marber; Amedeo Chiribiri; Philippe Pibarot; Simon R Redwood; Bernard D Prendergast
Journal:  Circ Cardiovasc Interv       Date:  2019-08-16       Impact factor: 6.546

Review 10.  Targeting Obesity and Diabetes to Treat Heart Failure with Preserved Ejection Fraction.

Authors:  Raffaele Altara; Mauro Giordano; Einar S Nordén; Alessandro Cataliotti; Mazen Kurdi; Saeed N Bajestani; George W Booz
Journal:  Front Endocrinol (Lausanne)       Date:  2017-07-17       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.